Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer
Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
In this clinical study, the investigators evaluate the efficacy and safety of S-588410 in
patients who underwent an adjuvant chemotherapy after the complete resection of
non-small-cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Tokyo University
Collaborators:
Fukushima Medical University Hokkaido University Kanagawa Cancer Center National Cancer Center Hospital East Shiga University of Medical Science Shionogi